The miR-9-5p/CXCL11 pathway is a key target of hydrogen sulfide-mediated inhibition of neuroinflammation in hypoxic ischemic brain injury

We previously showed that hydrogen sulfide(H2S)has a neuroprotective effect in the context of hypoxic ischemic brain injury in neonatal mice.However,the precise mechanism underlying the role of H2S in this situation remains unclear.In this study,we used a neonatal mouse model of hypoxic ischemic brain injury and a lipopolysaccharide-stimulated BV2 cell model and found that treatment with L-cysteine,a H2S precursor,attenuated the cerebral infarction and cerebral atrophy induced by hypoxia and ischemia and increased the expression of miR-9-5p and cystathionineβsynthase(a major H2S synthetase in the brain)in the prefrontal cortex.We also found that an miR-9-5p inhibitor blocked the expression of cystathionineβsynthase in the prefrontal cortex in mice with brain injury caused by hypoxia and ischemia.Furthermore,miR-9-5p overexpression increased cystathionine-β-synthase and H2S expression in the injured prefrontal cortex of mice with hypoxic ischemic brain injury.L-cysteine decreased the expression of CXCL11,an miR-9-5p target gene,in the prefrontal cortex of the mouse model and in lipopolysaccharide-stimulated BV-2 cells and increased the levels of proinflammatory cytokines BNIP3,FSTL1,SOCS2 and SOCS5,while treatment with an miR-9-5p inhibitor reversed these changes.These findings suggest that H2S can reduce neuroinflammation in a neonatal mouse model of hypoxic ischemic brain injury through regulating the miR-9-5p/CXCL11 axis and restoringβ-synthase expression,thereby playing a role in reducing neuroinflammation in hypoxic ischemic brain injury.

Comparative effects of α2δ-1 ligands in mouse models of colonic hypersensitivity

AIM: To investigate anti-hypersensitive effects of α2δ-1 ligands in non-inflammatory and inflammationassociated colonic hypersensitivity(CHS) mouse models.METHODS: To induce an inflammation-associated CHS, 1% dextran sulfate sodium(DSS) was administered to C57Bl/6J male mice, in drinking water, for 14 d. Regarding the non-inflammatory neonatal maternal separation(NMS)-induced CHS model, wild-type C57BI/6J pups were isolated from their mother from day 2 to day 14(P2 to P14), three hours per day(from 9:00 a.m. to 12:00 p.m.). Colorectal distension was performed by inflating distension probe from 20 μL to 100 μL by 20 μL increment step every 10 s. After a first colorectal distension(CRD), drugs were administered subcutaneously, in a cumulative manner,(Gabapentin at 30 mg/kg and 100 mg/kg; Pregabalin at 10 mg/kg and 30 mg/kg; Carbamazepine at 10 mg/kg and 30 mg/kg) and a second CRD was performed one hour after each injection.RESULTS: The visceromotor response(VMR) to CRD was increased by our NMS paradigm protocol in comparison to non-handled(NH) mice, considering the highest distension volumes(80 μL: 0.783 ± 0.056 mV /s vs 0.531 ± 0.034 m V/s, P < 0.05 and 100 μL: 1.087 ± 0.056 m V/s vs 0.634 ± 0.038 m V/s, P < 0.05 for NMS and NH mice, respectively). In the inflammationassociated CHS, DSS-treated mice showed a dramatic and significant increase in VMR at 60 and 80 μL distension volumes when compared to control mice(60 μL: 0.920 ± 0.079 m V/s vs 0.426 ± 0.100 m V/s P < 0.05 and 80 μL: 1.193 ± 0.097 mV /s vs 0.681 ± 0.094 mV /s P < 0.05 for DSS- and Water-treated mice, respectively). Carbamazepine failed to significantly reduce CHS in both models. Gabapentin significantly reduced CHS in the DSS-induced model for both subcutaneous injections at 30 or 100 mg/kg. Pregabalin s i g n i f i c a n t l y r e d u c e d V M R t o C R D i n t h e n o n-inflammatory NMS-induced CHS model for the acute subcutaneous administration of the highest cumulative dose(30 mg/kg) and significantly reduced CHS in lowdose DSS-treated mice in a dose-dependent manner. Finally, the percent decrease of AUC induced by acute GBP or Pregabalin treatment were higher in the inflammatory DSS-induced CHS model in comparison to the non-inflammatory NMS-induced CHS model.CONCLUSION: This preclinical study demonstrates α2δ-1 ligands efficacy on inflammation-associated CHS, highlighting their potential clinical interest in patients with chronic abdominal pain and moderate intestinal inflammation.

Pivotal role of long non-coding ribonucleic acid-X-inactive specific transcript in regulating immune checkpoint programmed death ligand 1 through a shared pathway between miR-194-5p and miR-155-5p in hepatocellular carcinoma

BACKGROUND Anti-programmed death therapy has thrust immunotherapy into the spotlight.However,such therapy has a modest response in hepatocellular carcinoma(HCC).Epigenetic immunomodulation is a suggestive combinatorial therapy with immune checkpoint blockade.Non-coding ribonucleic acid(ncRNA)driven regulation is a major mechanism of epigenetic modulation.Given the wide range of ncRNAs that co-opt in programmed cell-death protein 1(PD-1)/programmed death ligand 1(PD-L1)regulation,and based on the literature,we hypothesized that miR-155-5p,miR-194-5p and long non-coding RNAs(lncRNAs)X-inactive specific transcript(XIST)and MALAT-1 are involved in a regulatory upstream pathway for PD-1/PD-L1.Recently,nutraceutical therapeutics in cancers have received increasing attention.Thus,it is interesting to study the impact of oleuropein on the respective study key players.AIM To explore potential upstream regulatory ncRNAs for the immune checkpoint PD-1/PD-L1.METHODS Bioinformatics tools including microrna.org and lnCeDB software were adopted to detect targeting of miR-155-5p,miR-194-5p and lncRNAs XIST and MALAT-1 to PD-L1 mRNA,respectively.In addition,Diana tool was used to predict targeting of both aforementioned miRNAs to lncRNAs XIST and MALAT-1.HCC and normal tissue samples were collected for scanning of PD-L1,XIST and MALAT-1 expression.To study the interaction among miR-155-5p,miR-194-5p,lncRNAs XIST and MALAT-1,as well as PD-L1 mRNA,a series of transfections of the Huh-7 cell line was carried out.RESULTS Bioinformatics software predicted that miR-155-5p and miR-194-5p can target PDL1,MALAT-1 and XIST.MALAT-1 and XIST were predicted to target PD-L1 mRNA.PD-L1 and XIST were significantly upregulated in 23 HCC biopsies compared to healthy controls;however,MALAT-1 was barely detected.MiR-194 induced expression elevated the expression of PD-L1,XIST and MALAT-1.However,overexpression of miR-155-5p induced the upregulation of PD-L1 and XIST,while it had a negative impact on MALAT-1 expression.Knockdown of XIST did have an impact on PD-L1 expression;however,following knockdown of the negative regulator of X-inactive specific transcript(TSIX),PD-L1 expression was elevated,and abolished MALAT-1 activity.Upon co-transfection of miR-194-5p with siMALAT-1,PD-L1 expression was elevated.Co-transfection of miR-194-5p with siXIST did not have an impact on PD-L1 expression.Upon co-transfection of miR-194 with siTSIX,PD-L1 expression was upregulated.Interestingly,the same PD-L1 expression pattern was observed following miR-155-5p cotransfections.Oleuropein treatment of Huh-7 cells reduced the expression profile of PD-L1,XIST,and miR-155-5p,upregulated the expression of miR-194-5p and had no significant impact on the MALAT-1 expression profile.CONCLUSION This study reported a novel finding revealing that opposing acting miRNAs in HCC,have the same impact on PD-1/PD-L1 immune checkpoint by sharing a common signaling pathway.

A novel thermoregulated phosphine ligand used for the Rh-catalyzed hydroformylation of mixed C_(11-12) olefins in aqueous/organic biphasic system

A novel thermoregulated phosphine ligand PhP(CHCHO)CH(n=22) was synthesized and used for the Rh-catalyzed hydroformylation of mixed Colefins in aqueous/organic biphasic system.Under the optimized conditions,pressure =5 MPa (H:CO=1:1),phosphine/Rh =13(molar ratio),reaction time =6 h and temperature =130℃,the conversion of Colefins and the yield of aldehyde are 99%and 94%,respectively.The catalyst retained in aqueous phase can be easily separated from the product-containing organic phase by simple phase separation and the catalytic activity remains almost constant after four consecutive cycles.

Synthesis,Crystal Structure and Antitumor Activity of a Novel Zn(Ⅱ)Complex with 2-(Nicotinoyloxy)acetic Acid Ligand

A novel Zn（Ⅱ） complex, [ZnL2（H2O）4]·H2O（1, HL = 2-（nicotinoyloxy）acetic acid）, was synthesized using Zn（OAc）2·2H2O and 2-（nicotinoyloxy）acetic acid as raw materials. Its structure has been elucidated by elemental analysis, IR and single-crystal X-ray diffraction. The structural analysis revealed that complex 1 crystallizes in triclinic, space group P1 and the Zn（Ⅱ） atom is six-coordinated with two N atoms from two different 2-（nicotinoyloxy）acetate anion ligands and four O atoms from coordinated water molecules. Complex 1 forms a 3D network structure by O–H···O hydrogen bonds. The antitumor activities of 2-（nicotinoyloxy）acetic acid ligand and its Zn（Ⅱ） complex were evaluated against human lung adenocarcinoma A549 cells, human hepatoma SMMC-7721 cells and human colon carcinoma Wi Dr cells.

Two Fluorescent Complexes Assembled by Schiff Base 2-Methoxy-6-(phenyliminiomethyl) Phenolate Ligand

Two d10 metal complexes Zn（NCS）2（C14HI3NO2）2 （1） and [Cd（NO3）2（CI4HI3NO2）2]. 4H20 （2） assembled by 2-methoxy-6-（phenyliminiomethyl） phenolate ligand （C14H13NO2, HL） have been synthesized and characterized by elemental analysis, IR and TG The single-crystal X-ray diffraction studies demonstrated that complex 1 crystallizes in monoclinic, P21/c space group with a = 17.321（7）, b = 11.781（0）, c = 15.593（2） A, fl = 110.273（6）°, V = 2984.95 A3, Z = 4, C30H26N404SzZn, Mr = 636.04, F（000） = 1312, Dc = 1.415 g/cm3,μ（MoKa） = 1.004 mm＂1, the final R = 0.0403 and wR = 0.0900 for 21441 observed reflections with I 〉 20（/）. Complex 2 is of monoclinic system, space group C2/c with a = 16.7767（2）, b = 10.8989（2）, c = 17.4928（2） A, fl = 90.614（9）°, V= 3198.37 A3, Z = 4, C28H34N4O14Cd, Mr= 731.25, F（000） = 1528, Dc = 1.568 g＇cm^-3, μ（MoKa） = 0.757 mm-1, the final R = 0.0361 and wR = 0.0857 for 19811 observed reflections with I 〉 2σ（I）. The two complexes were formed by Schiff base 2-methoxy-6-（phenyliminiomethyl） phenolate ligand and formed a 3D supramolecular architecture by π-πstacking interactions. Moreover, the complexes are luminescent in the solid state. These observations indicate that the complexes are promising system for the development of potential photoactive materials.

A new free recoverable and reusable mono-alkaloid-type ligand and its use in preparation of ethyl(2R,3S)-2,3-dihydroxy-3-phenylpropionate

A new free recoverable and reusable mono-alkaloid-type ligand has been synthesized by a simple method. With highly polar groups, the ligand can be recycled and reused eight times to prepare ethyl （2R,3S）-2,3-dihydroxy-3-phenylpropionate with high yield and ee via asymmetric dihydroxylation （AD） reaction. C 2009 Sheng Yong Zhang. Published by Elsevier B.V. on behalf of Chinese Chemical Society. All rights reserved.

VO(Ⅱ)-组氨酸-π受体三元混配配合物的ESR波谱

钒的氨基酸配合物具有重要的生物和医学意义。VO（Ⅱ）-组氨酸配合物及VO（Ⅱ）-π受体二元配合物的ESR研究已有报道。但是VO（Ⅱ）-氨基酸-π受体三元配合物的结构及其ESR研究至今未见报道。本文考察了VOSO4与组氨酸（His）和邻菲啰啉（Phen）及α,α′-联吡啶（bipy）三元体系在不同酸度（pH=1～14）的乙二醇/水（1:1）溶液中低温（173K）ESR波谱,获得了不同pH条件下配合情况的详细信息。

Regulating the Electron-Deficient Component in A-DA1D-A Typed Small-Molecule Acceptors for High-Performance Organic Solar Cells

Fine-tuning of the electron-deficient unit in A-DA1D-A typed small-molecule acceptors (SMAs) plays a crucial role in developing efficient SMAs for organic solar cells (OSCs).Here,we developed a SMA based on benzo[4,5]thieno[2,3-b]quinoxaline,designated as QW1,as well as three SMAs based on 1-methylindoline-2,3-dione,identified as QW2,QW3,and QW4.Compared with QW2,QW1 displays slightly blue-shifted absorption spectra and a lower LUMO energy level due to the stronger electron-withdrawing capability of BTQx in contrast to MDO.On the other hand,the introduction of a bromine atom in QW3 and QW4 causes a blue shift in absorption and a reduction in the LUMO energy level compared to QW2.Density functional theory analysis reveals that QW1 exhibits the best molecular planarity,which endows QW1 with larger electron mobility and tighter molecular stacking.Consequently,PM6:QW1 device affords a better efficiency of 15.63% than those of the devices based on QW2 (14.25%),QW3 (13.21%) and QW4 (15.03%).Moreover,the QW4-based device yields the highest open-circuit voltage of 0.933 V,and the PM6:L8-BO:QW4 ternary device realizes a PCE of 19.03%.Overall,our work demonstrates that regulation of electron-deficient central units is an effective strategy to improve the photovoltaic performance of the resulting A-DA1D-A SMAs.

肝主动靶向载药系统抑制肝癌作用的研究进展

目的为新型肝主动靶向载药系统的研究和相关制剂的研发提供参考。方法查阅2017年至2023年中国知网、万方、维普、PubMed数据库配体修饰肝主动靶向载药系统相关文献,归纳并总结该系统类型及其用于肝癌治疗的研究现状,包括特异性纳米颗粒的设计、靶向载药系统在体内外的效果和存在的挑战,以及该系统未来的发展方向。结果与结论肝主动靶向载药系统为近年来兴起的新型给药策略,包括肝实质细胞、肝非实质细胞、肝肿瘤细胞3个靶向。肝癌细胞表面的特异性标志物是靶向递送化疗药物的主要目标,纳米颗粒是肝主动靶向载药系统中最常用的药物载体。通过调整纳米颗粒的材料、表面修饰等方法可实现药物向肝癌组织的高效、低毒及特异性递送。因此,尽管肝主动靶向给药系统仍有许多关键技术需要解决,如制备工艺较复杂、载药量小,肝细胞特异性配体发掘和应用不足,大量载体材料尚需完成从试验研究阶段向临床应用的转变,但其在肝癌靶向治疗方面已显示出极大的优越性,其发展趋势和应用前景值得重视。

Syntheses and Characterizations of Cd(Ⅱ) and Pr(Ⅲ) Complexes Based on 5-(Tetrazol-5-yl) Isophthalic Acid

Hydrothermal reactions of 5-（tetrazol-5-yl） isophthalic acid with cadmium nitrate/praseodymium nitrate led to two complexes of [Cd3（TZI）2（H2O）（11）]n（1） and [Pr（TZI）（H2O）5]n（2）. Their structures and properties were determined by X-ray diffraction, IR spectroscopy, fluorescence spectrum, thermal gravimetric analyses and elemental analysis. Complex 1 belongs to monoclinic system, I2/c space group, with a = 12.8688（3）, b = 18.0925（3）, c = 14.5190（3）A, β = 116.054（3）°, V =3036.92（13） A^3, Z = 4; complex 2 crystallizes in triclinic, space group P 1, with a = 7.9690（5）, b =9.7665（8）, c = 10.4353（9） A, α = 116.709（9）, β = 107.461（6）, γ = 95.671（6）°, V = 665.54（9）A^3 and Z =2. Complex 1 is a 3D planar structure. Complex 2 is a one-dimensional double chain configuration and extends into a 3D network by hydrogen bonds and π-π interactions.

A Corrugated 2D Mn(Ⅱ) Network:[Mn_3(μ-oxalate)_3(μ-4,4'-bpy)_2(4,4'-bpy)_2]_n

The title complex, [Mn3（μ-oxalate）3（μ-4,4′-bpy）2（4,4′-bpy）2]n, was synthesized and structurally characterized by X-ray crystallography. It crystallizes in the monoclinic, space group P2 1/c with a = 16.3222（6）, b = 16.2594（5）, c = 16.4885（5） A, β = 94.9900（10）°, V= 4359.3（2） A^3, Z = 4, Mn3C46N8O12H32, Mr = 1053.62, Dc = 1.605 g/cm^3, F（000） = 2140 and μ（MoKa） = 0.932 mm^-1. The structure was refined to R = 0.0578 and wR = 0.1061 for 4795 observed reflections （I 〉 2σ（I））. The oxalate anions behave as the bridging ligand and link two manganese atoms repeatedly to form infinite one-dimensional chains which further extend into a two-dimensional network by bridging 4,4′-bpy ligands.

Syntheses,Structures,and Luminescent Properties of Zinc(Ⅱ)and Silver(Ⅰ)Complexes Based on 1-(4′-Carboxylatobenzyl)-3-(pyrazin-2-yl)pyrazole

Two novel coordination compounds, [Zn（CBPP）2（H2O）2]·3H2O（1） and[Ag（CBPP）·2H2O]（2）（HCBPP = 1-（4？-carboxylatobenzyl）-3-（pyrazin-2-yl）pyrazole）, were hydrothermally synthesized and characterized. Compound 1 crystallizes in monoclinic, space group C2 with a = 26.221（4）, b = 8.4211（7）, c = 14.295（3）A, β = 114.561（8）°, V = 2705.9（2） A3, Dc = 1.587 g/cm3, C28H28Cl2N8O9 Zn, Mr = 685.97 F（000） = 1416, μ（Mo Kα） = 0.926 mm-1, Z = 4, R = 0.0287, w R = 0.1076 for 2818 observed reflections（I 〉 2σ（I））, and R = 0.0300, w R = 0.1110 for all data. In 1, each deprotonated CBPP-ligand with a bidentate coordination mode connects two Zn（II） atoms to generate a 1D helical chain along the b axis. The adjacent chains intersect with each other through hinged Zn（II） ions to build up an interesting two-dimensional network. Compound 2 crystallizes in monoclinic, space group P21/n with a = 6.3544（1）, b = 11.7195（3）, c = 19.3188（4）A, β = 94.297（2）°, V = 1434.64（5） A3, Dc = 1.894 g/cm3, C14H13 Ag N4O4, Mr = 409.15 F（000） = 816, μ（Mo Kα） = 11.536 mm-1, Z = 4, R = 0.0456 and w R = 0.1184 for 2402 observed reflections（I 〉 2σ（I））, and R = 0.0517, w R = 0.1275 for all data. In 2, each ligand binds two Ag（I） atoms in a tridentate coordination mode to form an infinite zigzag chain. Their thermal and photoluminescent properties were also investigated.

Synthesis, Crystal Structure and Characterization of α-(1-Benzimidazolyl)-hypnone Cobalt(Ⅱ) Complex: [CoCl(C_7H_5N_2CH_2COPh)_4]Br

The crystal structure of [CoCl(C_7H_5N_2CH_2COPh)_4]Br has been determined by means of X-ray crystallography. The molecular structure consists of a discrete [CoCl(C_7H_5N_2CH_2COPh)_4]+ cation and one Br- anion. In the [CoCl(C_7H_5N_2CH_2COPh)_4]+ cation, the coordination geometry of the central Co atom is square-pyramidal with four tertiary N atoms of benzimidazole from four α-(benzimidazol-1-yl)-hypnone ligands in the basal position and one chloride anion in the apical position. In the solid state, [CoCl(C_7H_5N_2CH_2COPh)_4]+ and Br- anion possess intermolecular and intramolecular interactions, which stabilize the crystal structure. The characterization of the title compound were also carried out by using elemeutal analysis, FTIR, UV spectrometries and TG-DSC.

Synergetic Alkoxy Side-Chain and Chlorine-Contained End Group Strategy toward High Performance Ultra-Narrow Bandgap Small Molecule Acceptors

Ultra-narrow bandgap(ultra-NBG)small molecule acceptors(SMAs)show great potential in organic solar cells(OSCs)due to the extended near-infrared(NIR)absorption.In this work,a synergetic alkoxy side-chain and chlorine-contained end group strategy is employed to achieve A-DA'D-A type ultra-NBG SMAs by introducing alkoxy chains with oxygen atom at the second position into the thiopheneβposition as well as replacing the F atoms with Cl atoms in the end group.As a result,the heptacyclic BZO-4F shows a redshifted absorption onset(960 nm)compared with Y11(932 nm)without oxygen atoms in the side chains.Then,the fluorinated end groups are substituted with the chlorinated ones to synthesize BZO-4Cl.The absorption onset of BZO-4Cl is further redshifted to 990 nm,corresponding to an optical ultra-NBG of 1.25 eV.When blending with the polymer donor PBDB-T,the binary devices based on PBDB-T:BZO-4F and PBDB-T:BZO-4Cl deliver power conversion efficiencies(PCEs)over 12%.Furthermore,ternary devices with the addition of BZ4F-O-1 into PBDB-T:BZO-4Cl system achieve the optimal PCE of 15.51%.This work proposes a synergetic alkoxy side-chain and chlorine-contained end group strategy to achieve A-DA'D-A type ultra-NBG SMAs,which is important for future molecular design.

Synthesis of Novel Tartaric Acid-derived Chiral Phosphite Ligands and Their Application in the Cu-catalyzed Conjugate Addition of Diethylzinc to Cyclic Enones

Five novel tropos （3R,4R）- and/or （3S,4S）-N-benzyltartarimide-derived biphenylphosphite ligands were synthesized and applied in the Cu-catalyzed asymmetric conjugate addition of diethylzinc to cyclic enones with up to 75% e.e. Compared with the reported ligand 1-N-benzylpyrrolidine-3,4-bis[（R）-1,1＇-binaphthyl-2,2＇-diyl]phosphite- L-tartaric acid, the issue that L-（＋）-tartaric acid backbone and （R）-binaphthyl showed strong matched/mismatched character was solved with these tropos ligands. It was found that the enantioselectivity was mainly controlled by the absolute configuration of N-benzyltartarimide backbone, and both enantiomers of the addition products can be obtained by simply changing the configuration of N-benzyltartarimide substituent.

设计新型液液两相催化体系:π配体离子液体

π配体催化剂与离子液体体系相结合有助于解决反应效率、产物分离和催化剂循环等一系列均相催化体系不易解决的难题 .近几年相关的研究逐渐深入 ,由简单地使用离子液体作为π配体催化反应的介质向利用离子液体自身结构的方向发展 ,相继出现了几类不同的研究思路 .例如 ,利用π配体催化剂与离子液体形成络合物 ,使用离子型π配体改善催化剂在离子液体中的溶解性 ,以及合成功能化阳离子或功能化阴离子的π配体离子液体 .本文结合这几类离子液体化学键联π配体 (简称π配体离子液体 )的研究进展 ,从离子液体功能化设计的角度探讨了π配体离子液体的合成思路 ,为设计具有更好催化性能的功能化离子液体体系提供借鉴 .

Intramolecular stacking interaction in mixed-ligand complexes containing ATP4-and aromatic N-heterocyclic ligands

The stability constants of the binary ML2+ and ternary M(ATP)L2? complexes, where L=Iq (isoquinoline) or BIm (benzimidazole) and M=Zn2+ or Cd2+, have been determined by potentiometric pH titration in aqueous solution at I=0.1 mol/L (NaClO4), T=25°C. The stability of the ternary complexes characterized by ΔlogKM=logKM(ATP)LM(ATP)L- logKMML corresponding to the equilibrium M(ATP)2? + ML2+ = M(ATP)L2? + M2+ in higher than what would be expected on statistical grounds. The increase may be related to the stacking interaction between the aromatic ring of the ligands L and the purine moiety of ATP4–. 1H NMR studies of Zn2+/ATP4?/L confirm the presence of stacking in the ternary complexes. It is concluded that the strength of the intramolecular stacking interaction ia dependent on the structure of the aromatic ring of the ligand L and the formation of a metal ion bridge. Possible implications an discussed briefly.

雷公藤多苷对rmMIF诱导大鼠成纤维样滑膜细胞增殖及RANKL/OPG表达的影响

目的观察雷公藤多苷(tripterygium glycoside,TG)对重组鼠巨噬细胞移动抑制因子(recombinantmouse macrophage migration inhibitory factor,rmMIF)诱导大鼠成纤维样滑膜细胞(fibroblast-like synoviocytes,FLS)的增殖及其细胞核因子-κB受体活化因子配体(receptor activator of nuclear factor kappaB ligand,RANKL)、骨保护素(osteo-protegerin,OPG)表达的干预作用。方法采用大鼠FLS细胞株RSC-364,常规方法复苏、培养、传代,实验用3～5代FLS。分为4组:空白对照组加入200μl DMEM培养液,另3组分别加入200μl含rmMIF(200 ng/ml)(MIF组)、rm-MIF(200 ng/ml)+TG(20μg/ml)(MIF+TG组)、rmMIF(200ng/ml)+MTX(0.5μg/ml)(MIF+MTX组)的DMEM培养液。置37℃、5%CO2孵箱培养48 h。MTT法检测FLS的增殖活性;免疫组化法检测滑膜细胞OPG/RANKL的表达;酶联免疫吸附试验(ELISA)检测FLS上清液OPG、RANKL表达。结果 MIF组增殖活性高于空白对照组,MIF+TG组、MIF+MTX组增殖活性低于空白对照组和MIF组(P<0.01)。MIF+TG组和MIF+MTX组细胞OPG标记指数均高于空白对照组和MIF组,MIF+TG组OPG标记指数高于MIF+MTX组(P<0.01,P<0.05)。MIF组细胞RANKL标记指数高于空白对照组,MIF+TG组、MIF+MTX组RANKL标记指数均低于MIF组(P<0.05,P<0.01)。MIF组上清液RANKL浓度和RANKL/OPG值均高于空白对照组,MIF+MTX组上清液RANKL浓度低于空白对照组(P<0.05,P<0.01);MIF+TG组和MIF+MTX组上清液RANKL浓度和RANKL/OPG值均低于MIF组(P<0.01)。结论 rmMIF可促进体外培养大鼠FLS增殖,上调FLS的RANKL表达和RANKL/OPG值;TG抑制rmMIF诱导的大鼠FLS增殖、降低rmMIF诱导大鼠FLS分泌RANKL、下调FLS的RANKL表达和RANKL/OPG比值,可能是其治疗类风湿关节炎的骨免疫学机制之一。

Axially Dissymmetric Chiral (R)-N,N′-Bis(2-hydroxy-3,5-di-tert-butyl-arylmethyl)-1,1′-binaphthalene-2,2′-diamine as Chiral Ligands in the Reaction of Diethylzinc to Aldehydes

Chiral ligand (R)-N, N'-Bis(2-hydroxy-3,5-di- tert-butyl-aryl-methyl)-1, 1'-binaphthalene-2,2'-diamine derived from the reduction of Schiff base (R)-2,2'-bis (3,5-di-tert-butyl-2-hy-droxybenzylideneamino)-1, 1'-binaphthyl with LiAIH(4) is fairly effective in the asymmetric addition reaction of diethylzinc to aldehydes by which good yields (46%-94%) of the corresponding sec-alcohols can be obtained in moderate ee (51%-79%) with R configuration for a variety of aldehydes.